axial spondyloarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged 18to 45 years; (2) defined using the ASAS axial spondyloarthritis criteria in 2009; (3) identified as active axSpA during screening and baseline examination; (4) still met active axSpA when NSAIDs were used for 4 weeks and / or csDMARDs for 8 weeks before treatment (before randomization); (5) with the negative pregnancy test in female patient with child-bearing age; (6) agreed to take effective contraceptive measures during the study in fertile female; (7) willing to receive treatment according to the program and follow-up on time; (8) understand and sign informed consent form.
Exclusion criteria
Exclusion criteria: (1) diagnosed with other inflammatory arthritis, such as rheumatoid arthritis et al; (2) diagnosed with metabolic osteopathy; (3) diagnosed with infectious arthritis, such as intervertebral disc infection; (4) with complete spinal ankyloses; (5) occurred hemorrhagic disease or coagulation dysfunction; (6) with thrombosis in the treatment area; (7) accompanied by malignant diseases; (8) with mechanical low back pain; (9) with severe skin disease or ulceration in the treated area; (10) pregnant women; (11) with a history of severe drug abuse or alcohol abuse or mental illness with clinical symptoms; (12) participated in any clinical trial within 3 months before randomization; (13) not suitable for the study judgment by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bath Ankylosing Spondylitis Disease Activity Index;Visual Analogue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ankylosing Spondylitis Disease Activity Score;Morning stiffness time;Patient's global assessment;Physician's global assessment;Bath Ankylosing Spondylitis Functional Index;MRI Score By Spondyloarthritis Research Consortium of Canada;Erythrocyte sedimentation rate;C-reactive protein;Measurement of spinal mobility; | — |
Countries
China
Contacts
Beijing Jishuitan Hospital